Filing metadata

Accession number
0001140361-17-025046
Form type
Form 3
Filer
Spyre Therapeutics, Inc.
CIK
CIK 1636282
Filed
Jun 14, 2017
Reporting period
May 22, 2017
Description
Initial ownership

Explore SEC Filings Hub